2015•Tumor BiologyRequires access

Targeting of mTORC2 may have advantages over selective targeting of mTORC1 in the treatment of malignant pheochromocytoma

Xiaohua Zhang, Xianjin Wang, Tianyuan Xu, Shan Zhong, Zhoujun Shen

Open publisher page 26 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 26 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: mTORC2, mTORC1, PI3K/AKT/mTOR pathway, Cancer research, Cell growth, Apoptosis, Cell biology, Chemistry

Back to paper search Browse research topics Original source

Targeting of mTORC2 may have advantages over selective targeting of mTORC1 in the treatment of malignant pheochromocytoma — Research Paper | ScholarLens